Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients

Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol

(2013) Gloria Brombo et al.   PLoS One

Role of insulin resistance in endothelial dysfunction

(2013) Ranganath Muniyappa et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation

(2012) Stella Bernardi et al.   CLINICAL SCIENCE

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

(2012) A. Bisgin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus

(2011) Naoya Kawano et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice

(2011) B. A. Di Bartolo et al.   DIABETOLOGIA

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults

(2010) Stefano Volpato et al.   ATHEROSCLEROSIS

Treatment With Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes

(2010) G. Zauli et al.   DIABETES

TRAIL/Apo2L Mediates the Release of Procoagulant Endothelial Microparticles Induced by Thrombin In Vitro

(2009) Stéphanie Simoncini et al.   CIRCULATION RESEARCH

Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes

(2009) G. D. Xiang et al.   DIABETIC MEDICINE

Prognostic value of apoptosis markers in advanced heart failure patients

(2009) A. Niessner et al.   EUROPEAN HEART JOURNAL

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction

(2009) Paola Secchiero et al.   PLoS One

Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes

(2008) Clifford J. Bailey   CARDIOVASCULAR DRUGS AND THERAPY

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

(2008) Jianping Weng et al.   LANCET